Advertisement

Related Videos

Welcome and Introduction to Vi3C

Amit Sanyal, MD: A Clinician’s Perspective

Gary L. Rosner, ScD, on Bayesian Non-Inferiority

Sarah Yim, MD, on Clinical Development of Biosimilars: Lessons for Interventional Pharmacoeconomics

Boon-Cher Goh, MD, on Cancer Drugs in Singapore: 3As (Availability, Accessibility, and Affordability)

Advertisement

Advertisement




Oct
26
Today In Oncology
High-Risk Melanoma Personalized mRNA Vaccine Plus Immunotherapy Reduces Risk of Recurrence After Surgery
GLP-1 RA Use Lower Among Adults With Both Diabetes and a History of Cancer
Triplet Therapy With Abiraterone Improves OS Long-Term in Metastatic Castration-Sensitive Prostate Cancer
Final MINT Study Results Strengthen Real-World Evidence for Mogamulizumab in Mycosis Fungoides and Sezary Syndrome
FDA Grants Traditional Approval to Pembrolizumab for TMB-H Solid Tumors
View More 
Advertisement
© 2026 HSP News Service, L.L.C.
Conexiant Oncology Logo